Osteoporosis treatment disparities: A 6-year aggregate analysis from national survey data

Osteoporosis International

Volumn 25, Issue 9, 2014, Pages 2199-2208

  Cunningham, T D ^a   Di Pace, B S ^a   Ullal, J ^a  

^a EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

Author keywords

Healthcare disparities; Osteoporosis; Treatment

Indexed keywords

ALENDRONIC ACID; CALCITONIN; CONJUGATED ESTROGEN; DENOSUMAB; ESTRADIOL; IBANDRONIC ACID; RALOXIFENE; RISEDRONIC ACID; ZOLEDRONIC ACID; BONE DENSITY CONSERVATION AGENT;

ADULT; ARTHRITIS; ARTICLE; BODY MASS; BONE DENSITY; DUAL ENERGY X RAY ABSORPTIOMETRY; FAMILY HISTORY; FEMALE; FRAGILITY FRACTURE; HEALTH CARE; HEALTH CARE DISPARITY; HEALTH CARE PERSONNEL; HEALTH CARE SURVEY; HIP FRACTURE; HUMAN; MAJOR CLINICAL STUDY; MALE; OBESITY; OSTEOPOROSIS; POSTMENOPAUSE; PRESCRIPTION; PRIORITY JOURNAL; QUESTIONNAIRE; RACE DIFFERENCE; SELF REPORT; SPINE FRACTURE; AGED; DRUG UTILIZATION; MIDDLE AGED; NUTRITION; OSTEOPOROTIC FRACTURES; PATHOPHYSIOLOGY; PHOTON ABSORPTIOMETRY; PHYSIOLOGY; PROCEDURES; SOCIOECONOMICS; STATISTICS AND NUMERICAL DATA; UNITED STATES; VERY ELDERLY;

ABSORPTIOMETRY, PHOTON; AGED; AGED, 80 AND OVER; BODY MASS INDEX; BONE DENSITY; BONE DENSITY CONSERVATION AGENTS; DRUG PRESCRIPTIONS; DRUG UTILIZATION; FEMALE; HEALTHCARE DISPARITIES; HUMANS; MALE; MIDDLE AGED; NUTRITION SURVEYS; OSTEOPOROSIS; OSTEOPOROTIC FRACTURES; SOCIOECONOMIC FACTORS; UNITED STATES;

EID: 84906303130     PISSN: 0937941X     EISSN: 14332965     Source Type: Journal    
DOI: 10.1007/s00198-014-2747-9     Document Type: Article

References (21)

1. Consensus Development Conference (1993) Consensus development conference: diagnosis, prophylaxis, and treatment of osteoporosis. Am J Med 94:646-650
2. National Osteoporosis Foundation (2013) The NOF releases new data detailing the prevalence of osteoporosis. http://www.nof.org/news/1009. Accessed 1 December 2013
3. National Osteoporosis Foundation (2013) Clinician's guide to prevention and treatment of osteoporosis. National Osteoporosis Foundation. http://nof.org/files/nof/public/content/resource/913/files/580.pdf. Accessed 1 December 2013
4. Brennan RM, Wactawski-Wende J, Crespo CJ, Dmochowski J (2004) Factors associated with treatment initiation after osteoporosis screening. Am J Epidemiol 160:475-483 (Pubitemid 39166981)
5. International Osteoporosis Foundation (2013) Facts and statistics. International Osteoporosis Foundation. http://www.iofbonehealth.org/facts- statistics. Access 1 December 2013
6. Sutton A, Dian L, Guy P (2011) Osteoporosis in men: an underrecognized and undertreated problem. BCMJ 53(10):535-540
7. DeJesus RS, Chaudhry R, Angstman KB, Cha SS, Tulledge-Scheitel SM, Kesman RL, Bernard ME, Stroebel RJ (2011) Predictors of osteoporosis screening completion rates in a primary care practice. Popul Health Manag 14:243-247
8. Nayak S, Roberts MS, Greenspan SL (2009) Factors associated with osteoporosis screening and recommendations for osteoporosis screening in older adults. J Gen Intern Med 24:585-591
9. Davisson L, Warden M, Manivannan S, Kolar M, Kincaid C, Bashir S, Layne R (2009) Osteoporosis screening: factors associated with bone mineral density testing of older women. J Womens Health (Larchmt) 18:989-994
10. WardMA, Xu Y, Viswanathan HN, Stolshek BS, Clay B, Adams JL, Kallich JD, Fine S, Saag KG (2013) Association between osteoporosis treatment change and adherence, incident fracture, and total healthcare costs in a Medicare Advantage Prescription Drug plan. Osteoporos Int 24:1195-1206
11. Greenspan SL, Wyman A, Hooven FH et al (2012) Predictors of treatment with osteoporosis medications after recent fragility fractures in a multinational cohort of postmenopausal women. J Am Geriatr Soc 60:455-461
12. National Health and Nutrition Examination Survey (2013) About the National Health and Nutrition Examination Survey. Centers for Disease Control and Prevention. http://www.cdc.gov/nchs/nhanes/about-nhanes.htm. Accessed 1 December 2013
13. Kanis JA, McCloskey EV, Johansson H, Oden A, Melton LJ 3rd, Khaltaev N (2008) A reference standard for the description of osteoporosis. Bone 42:467-475
14. The International Society for Clinical Densitometry 2013 Official Positions. http://www.iscd.org/official-positions/2013-iscd-official-positions- adult/
15. Hosmer DW, Lemeshow S (1989) Applied logistic regression. Wiley, New York
16. Meadows ES, Mitchell BD, Bolge SC, Johnston JA, Col NF (2012) Factors associated with treatment of women with osteoporosis or osteopenia from a national survey. BMC Womens Health 12:1
17. Looker CA, Borrud LG, Dawson-Hughes B, Shepherd JA, Wright NC (2012) Osteoporosis or low bone mass at the femur neck or lumbar spine in older adults: United States, 2005-2008. NCHS Data Brief No. 93 http://www.cdc.gov/nchs/data/ databriefs/db93.pdf
18. Curtis JR, McClure LA, Delzell E, Howard VJ, Orwoll E, Saag KG, Safford M, Howard G (2009) Population-based fracture risk assessment and osteoporosis treatment disparities by race and gender. J Gen Intern Med 24(8):956-62
19. Solomon DH, Morris C, Cheng H, Cabral D, Katz JN, Finkelstein JS, Avorn J (2005) Medication use patterns for osteoporosis: an assessment of guidelines, treatment rates, and quality improvement interventions. Mayo Clin Proc 80(2):194-202 (Pubitemid 40194534)
20. McLeod KM, Johnson CS (2011) A systematic review of osteoporosis health beliefs in adult men and women. J Osteoporosis 2011:197454
21. Wardlaw GM (1996) Putting body weight and osteoporosis into perspective. Am J Clin Nutr 63:433s-436s